These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9032305)

  • 1. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1997 Mar; 71(3):1766-75. PubMed ID: 9032305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) nuclear antigen 1 colocalizes with cellular replication foci in the absence of EBV plasmids.
    Ito S; Yanagi K
    J Virol; 2003 Mar; 77(6):3824-31. PubMed ID: 12610157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids.
    Kanda T; Otter M; Wahl GM
    Mol Cell Biol; 2001 May; 21(10):3576-88. PubMed ID: 11313483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.
    Leight ER; Sugden B
    Rev Med Virol; 2000; 10(2):83-100. PubMed ID: 10713596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins.
    Aiyar A; Sugden B
    J Biol Chem; 1998 Dec; 273(49):33073-81. PubMed ID: 9830062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear antigen-1 is highly colocalized with interphase chromatin and its newly replicated regions in particular.
    Ito S; Gotoh E; Ozawa S; Yanagi K
    J Gen Virol; 2002 Oct; 83(Pt 10):2377-2383. PubMed ID: 12237418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
    Koons MD; Van Scoy S; Hearing J
    J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.
    Lee MA; Diamond ME; Yates JL
    J Virol; 1999 Apr; 73(4):2974-82. PubMed ID: 10074147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
    Dhar V; Schildkraut CL
    Mol Cell Biol; 1991 Dec; 11(12):6268-78. PubMed ID: 1658629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.